what dose of bpc 157 should i take BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or What Is BPC-157? A Medical
Description
(This dosing is mentioned for completeness

Hypercobalaminaemia Is Associated with Hepatic and Neoplastic Disease in Cats: A Cross Sectional Study

Hickson, Dietary Magnesium May Be Protective for Aging of Bone and Skeletal Muscle in Middle and Younger Older Age Men and Women: Cross-Sectional Findings from the UK Biobank Cohort, National Institutes of Health

Finally, the mRNA expression studies showed decreased VEGF gene expression in perforated rat stomachs [144] and strongly elevated VEGFr2 gene expression in the brains of stroked rats that received BPC 157 therapy following reperfusion [145]

Administer via subcutaneous injection as per your protocol
